"shire plc" - Google News

How Takeda's $62 Billion Shire Deal Reshapes Pharma World - Bloomberg.com

Tue, 08 Jan 2019 08:00:00 GMT

How Takeda's $62 Billion Shire Deal Reshapes Pharma World Bloomberg.com

Allergan Does Not Intend to Make an Offer for Shire plc; Strategic Review Continues - AbbVie News Center

Thu, 19 Apr 2018 07:00:00 GMT

Allergan Does Not Intend to Make an Offer for Shire plc; Strategic Review Continues AbbVie News Center

Five years after closing the Shire deal, Takeda is ready to harvest from its latest reinvention - Pharma Voice

Fri, 19 Jan 2024 08:00:00 GMT

Five years after closing the Shire deal, Takeda is ready to harvest from its latest reinvention Pharma Voice

Shire Makes Unsolicited $30.6 Billion Bid for Baxalta - WSJ

Wed, 05 Aug 2015 07:00:00 GMT

Shire Makes Unsolicited $30.6 Billion Bid for Baxalta WSJ

Drugmaker Shire to buy Baxalta for $32 billion after 6-month pursuit - Reuters

Mon, 11 Jan 2016 08:00:00 GMT

Drugmaker Shire to buy Baxalta for $32 billion after 6-month pursuit Reuters

Takeda Pharmaceutical shareholders approve $62 billion bid for Shire - MarketWatch

Tue, 04 Dec 2018 08:00:00 GMT

Takeda Pharmaceutical shareholders approve $62 billion bid for Shire MarketWatch

Shire (SHPG), Takeda Shareholders Approve $62 Billion Merger - Yahoo Finance

Thu, 06 Dec 2018 08:00:00 GMT

Shire (SHPG), Takeda Shareholders Approve $62 Billion Merger Yahoo Finance

A deal to buy Shire would make Takeda the new king of Cambridge - The Business Journals

Wed, 28 Mar 2018 07:00:00 GMT

A deal to buy Shire would make Takeda the new king of Cambridge The Business Journals

Lonza snatches Shire facility as biologics manufacturing rakes in returns - BioPharma Dive

Thu, 05 Oct 2017 07:00:00 GMT

Lonza snatches Shire facility as biologics manufacturing rakes in returns BioPharma Dive

Takeda set to swallow Shire - Chemistry World

Mon, 14 May 2018 07:00:00 GMT

Takeda set to swallow Shire Chemistry World

Shire and GlaxoSmithKline enter agreement to co-promote VYVANSEÂ® (lisdexamfetamine dimesylate) CII for the treatment of adults - Fierce Biotech

Tue, 31 Mar 2009 07:00:00 GMT

Shire and GlaxoSmithKline enter agreement to co-promote VYVANSEÂ® (lisdexamfetamine dimesylate) CII for the treatment of adults Fierce Biotech

Shire to sell its oncology business for $2.4 billion - The Boston Globe

Mon, 16 Apr 2018 07:00:00 GMT

Shire to sell its oncology business for $2.4 billion The Boston Globe

item1 - SEC.gov

Wed, 22 Jun 2016 15:00:07 GMT

item1 SEC.gov

Takeda Downgrade Looms After Shareholders Approve Shire Deal - Bloomberg.com

Wed, 05 Dec 2018 08:00:00 GMT

Takeda Downgrade Looms After Shareholders Approve Shire Deal Bloomberg.com

Japan's Takeda clinches $62 billion Shire deal as pharma M&A rolls on - Reuters

Mon, 07 May 2018 07:00:00 GMT

Japan's Takeda clinches $62 billion Shire deal as pharma M&A rolls on Reuters

Is Shire plc’s (LON:SHP) PE Ratio A Signal To Buy For Investors? - Yahoo Finance

Mon, 05 Feb 2018 08:00:00 GMT

Is Shire plc’s (LON:SHP) PE Ratio A Signal To Buy For Investors? Yahoo Finance

Servier launches Boston-based division after buying Shire cancer unit - The Business Journals

Tue, 17 Jul 2018 07:00:00 GMT

Servier launches Boston-based division after buying Shire cancer unit The Business Journals

Shire moving more than 500 jobs to Mass. - The Boston Globe

Wed, 19 Nov 2014 08:00:00 GMT

Shire moving more than 500 jobs to Mass. The Boston Globe

Takeda Wins Battle for Shire With $62 Billion Deal - WSJ

Tue, 08 May 2018 07:00:00 GMT

Takeda Wins Battle for Shire With $62 Billion Deal WSJ

AbbVie says $55 billion acquisition of Shire officially dead - Reuters

Tue, 21 Oct 2014 07:00:00 GMT

AbbVie says $55 billion acquisition of Shire officially dead Reuters

Shire and Jennifer Aniston Want to Inspire People to Show Their Eyes Some Love and Help Raise Awareness of Chronic Dry Eye - MultiVu

Thu, 25 Aug 2016 07:00:00 GMT

Shire and Jennifer Aniston Want to Inspire People to Show Their Eyes Some Love and Help Raise Awareness of Chronic Dry Eye MultiVu

Shire plc: Rule 2.9 Announcement - GlobeNewswire

Fri, 17 Aug 2018 07:00:00 GMT

Shire plc: Rule 2.9 Announcement GlobeNewswire

Shire announces new CFO to join in 2018 - BioPharma Dive

Tue, 21 Nov 2017 08:00:00 GMT

Shire announces new CFO to join in 2018 BioPharma Dive

Shire’s new Elaprase formulation fails late-stage trial - BioPharma Dive

Tue, 19 Dec 2017 08:00:00 GMT

Shire’s new Elaprase formulation fails late-stage trial BioPharma Dive

Teva launches generic version of Shire’s top-selling internal medicine - BioPharma Dive

Wed, 28 Mar 2018 07:00:00 GMT

Teva launches generic version of Shire’s top-selling internal medicine BioPharma Dive

Takeda Shares Fall Most Since 2009 on Possible Bid for Shire - Bloomberg.com

Wed, 28 Mar 2018 07:00:00 GMT

Takeda Shares Fall Most Since 2009 on Possible Bid for Shire Bloomberg.com

AbbVie to Buy Shire for $54 Billion - WSJ

Fri, 18 Jul 2014 07:00:00 GMT

AbbVie to Buy Shire for $54 Billion WSJ

Takeda Acquisition Of Shire Officially Closes, CEO Christophe Weber Shares His Plans For The Future - Forbes

Mon, 07 Jan 2019 08:00:00 GMT

Takeda Acquisition Of Shire Officially Closes, CEO Christophe Weber Shares His Plans For The Future Forbes

Shire launches newest ADHD med Mydayis - BioPharma Dive

Wed, 30 Aug 2017 07:00:00 GMT

Shire launches newest ADHD med Mydayis BioPharma Dive

Shire takeover may take months to finish - The Boston Globe

Wed, 25 Apr 2018 07:00:00 GMT

Shire takeover may take months to finish The Boston Globe

Shire's $2.4 Billion Cancer-Unit Sale Sweetens Takeda Appeal - Bloomberg.com

Mon, 16 Apr 2018 07:00:00 GMT

Shire's $2.4 Billion Cancer-Unit Sale Sweetens Takeda Appeal Bloomberg.com

Shire says ADHD drug meets main goal of study - Reuters

Wed, 29 Jun 2016 07:00:00 GMT

Shire says ADHD drug meets main goal of study Reuters

L.A. Jobs on the Line as Opponents Battle $62 Billion Takeda Buyout of Shire - Los Angeles Business Journal

Mon, 11 Jun 2018 07:00:00 GMT

L.A. Jobs on the Line as Opponents Battle $62 Billion Takeda Buyout of Shire Los Angeles Business Journal

Pharma mania: Shire offers $30B for Baxalta - USA Today

Tue, 04 Aug 2015 07:00:00 GMT

Pharma mania: Shire offers $30B for Baxalta USA Today

Will Allergan buy Shire to fend off Valeant and Ackman? - CNBC

Thu, 24 Apr 2014 07:00:00 GMT

Will Allergan buy Shire to fend off Valeant and Ackman? CNBC

Shire withdraws FDA application for Fabry drug - Reuters

Wed, 14 Mar 2012 07:00:00 GMT

Shire withdraws FDA application for Fabry drug Reuters

Elliott Sues AbbVie Over Failed Inversion Deal With Shire - WSJ

Fri, 05 Aug 2016 07:00:00 GMT

Elliott Sues AbbVie Over Failed Inversion Deal With Shire WSJ

Court upholds Shire Vyvanse patents - drugdiscoverytrends.com

Wed, 25 Jun 2014 07:00:00 GMT

Court upholds Shire Vyvanse patents drugdiscoverytrends.com

Shire to Sell Oncology Unit for $2.4 Billion as Takeda Mulls Takeover - WSJ

Mon, 16 Apr 2018 07:00:00 GMT

Shire to Sell Oncology Unit for $2.4 Billion as Takeda Mulls Takeover WSJ

Shire said to consider bid for NPS as it revisits takeovers - Worcester Telegram

Sun, 21 Dec 2014 08:00:00 GMT

Shire said to consider bid for NPS as it revisits takeovers Worcester Telegram

Shire pharmaceutical makes $30bn move for Baxalta - The Guardian

Tue, 04 Aug 2015 07:00:00 GMT

Shire pharmaceutical makes $30bn move for Baxalta The Guardian

Whisky and Apologies Aided Takeda's $62 Billion Shire Gamble - Bloomberg.com

Thu, 10 May 2018 07:00:00 GMT

Whisky and Apologies Aided Takeda's $62 Billion Shire Gamble Bloomberg.com

Shire-Baxalta Merger Will Create a Giant in Drugs for Rare Diseases (Published 2016) - The New York Times

Mon, 11 Jan 2016 08:00:00 GMT

Shire-Baxalta Merger Will Create a Giant in Drugs for Rare Diseases (Published 2016) The New York Times

First non-Japanese CEO of Takeda has set out 2 objectives: to be an R&D-driven firm and to build global scale - Business Insider

Thu, 18 Feb 2021 08:00:00 GMT

First non-Japanese CEO of Takeda has set out 2 objectives: to be an R&D-driven firm and to build global scale Business Insider

Takeda shareholder group aims to block $62 billion Shire deal - Reuters

Mon, 11 Jun 2018 07:00:00 GMT

Takeda shareholder group aims to block $62 billion Shire deal Reuters

Takeda, Shire shareholders approve $62B tie-up - The Business Journals

Wed, 05 Dec 2018 08:00:00 GMT

Takeda, Shire shareholders approve $62B tie-up The Business Journals

FDA approves Shire's Vyvanse for binge-eating disorder - PhillyVoice

Thu, 05 Feb 2015 08:00:00 GMT

FDA approves Shire's Vyvanse for binge-eating disorder PhillyVoice

Why AbbVie may get easier ride than Pfizer in UK bid - CNBC

Fri, 20 Jun 2014 07:00:00 GMT

Why AbbVie may get easier ride than Pfizer in UK bid CNBC

Novartis to Buy Takeda Eye Drug Assets in $5.3 Billion Deal - Bloomberg.com

Thu, 09 May 2019 07:00:00 GMT

Novartis to Buy Takeda Eye Drug Assets in $5.3 Billion Deal Bloomberg.com

Takeover whispers about Shire growing much louder - The Boston Globe

Thu, 29 Mar 2018 07:00:00 GMT

Takeover whispers about Shire growing much louder The Boston Globe

After Takeda merger, Shire exec jumps to top post at Sobi - The Business Journals

Wed, 01 May 2019 07:00:00 GMT

After Takeda merger, Shire exec jumps to top post at Sobi The Business Journals

Shire Under Pressure to Break Up the Business - BioSpace

Wed, 18 Oct 2017 07:00:00 GMT

Shire Under Pressure to Break Up the Business BioSpace

Irish bioscience company opens new $1.2 billion Georgia plant - The Business Journals

Fri, 12 Oct 2018 07:00:00 GMT

Irish bioscience company opens new $1.2 billion Georgia plant The Business Journals

Shire Plc Delist During Offer By Takeda Pharmaceutical Company Limited - DirectorsTalk Interviews

Wed, 09 Jan 2019 08:37:30 GMT

Shire Plc Delist During Offer By Takeda Pharmaceutical Company Limited DirectorsTalk Interviews

Takeda completes acquisition of Shire, becoming a global, values-based, R&D-driven biopharmaceutical leader - The Covington News

Tue, 08 Jan 2019 08:00:00 GMT

Takeda completes acquisition of Shire, becoming a global, values-based, R&D-driven biopharmaceutical leader The Covington News

The next UK pharma takeover target may be… - CNBC

Tue, 03 Jun 2014 07:00:00 GMT

The next UK pharma takeover target may be… CNBC

Shire earns FDA approval for Social Circle plant - The Covington News

Thu, 21 Jun 2018 07:00:00 GMT

Shire earns FDA approval for Social Circle plant The Covington News

Takeda Grabs Shire At Last After Long Pursuit - Citeline News & Insights

Tue, 08 May 2018 07:00:00 GMT

Takeda Grabs Shire At Last After Long Pursuit Citeline News & Insights

Deal of the Year: Takeda buys Shire - BioPharma Dive

Mon, 03 Dec 2018 08:00:00 GMT

Deal of the Year: Takeda buys Shire BioPharma Dive

Takeda closes $62B purchase of Shire, creating largest Mass. biotech employer - The Business Journals

Mon, 07 Jan 2019 08:00:00 GMT

Takeda closes $62B purchase of Shire, creating largest Mass. biotech employer The Business Journals

Takeda completes Shire acquisition - Pharmafile

Tue, 08 Jan 2019 08:00:00 GMT

Takeda completes Shire acquisition Pharmafile

Takeda Plans to Sell $10 Billion in Non-Core Assets to Offset Debt of the Shire Deal - BioSpace

Wed, 09 Jan 2019 08:00:00 GMT

Takeda Plans to Sell $10 Billion in Non-Core Assets to Offset Debt of the Shire Deal BioSpace

Modern Technology and a Multi-Screen Lifestyle Viewed as Important Factors in Rising Prevalence of Dry Eye Disease - MultiVu

Mon, 17 Oct 2016 07:00:00 GMT

Modern Technology and a Multi-Screen Lifestyle Viewed as Important Factors in Rising Prevalence of Dry Eye Disease MultiVu

Baxalta to Collaborate With Symphogen, as It Nears Shire Merger Deal - WSJ

Mon, 04 Jan 2016 08:00:00 GMT

Baxalta to Collaborate With Symphogen, as It Nears Shire Merger Deal WSJ

Shire targeted in takeover bid - The Covington News

Wed, 25 Apr 2018 07:00:00 GMT

Shire targeted in takeover bid The Covington News

For Takeda Pharmaceutical’s CFO, ‘Speed and Agility’ Were Key to Shire Tie-Up - WSJ

Wed, 01 Mar 2023 08:00:00 GMT

For Takeda Pharmaceutical’s CFO, ‘Speed and Agility’ Were Key to Shire Tie-Up WSJ

Shire hires Citi as braces for takeover bids: Sources - CNBC

Mon, 16 Jun 2014 07:00:00 GMT

Shire hires Citi as braces for takeover bids: Sources CNBC

Standoff Over Shire’s Pursuit of Baxalta Nears an End - WSJ

Wed, 16 Dec 2015 08:00:00 GMT

Standoff Over Shire’s Pursuit of Baxalta Nears an End WSJ

AbbVie, Shire Terminate Year’s Biggest Deal - WSJ

Mon, 20 Oct 2014 07:00:00 GMT

AbbVie, Shire Terminate Year’s Biggest Deal WSJ

Shire Officially Snaps Up NPS Pharmaceuticals, Inc. in $5.2 Billion Deal - BioSpace

Sun, 11 Jan 2015 08:00:00 GMT

Shire Officially Snaps Up NPS Pharmaceuticals, Inc. in $5.2 Billion Deal BioSpace

Shire Agrees to Buy Baxalta for $32 Billion - WSJ

Mon, 11 Jan 2016 08:00:00 GMT

Shire Agrees to Buy Baxalta for $32 Billion WSJ

Shire wires Cambridge expansion - Boston Herald

Wed, 23 Nov 2016 08:00:00 GMT

Shire wires Cambridge expansion Boston Herald

AbbVie and Shire seal $55B, tax-slashing deal - USA Today

Fri, 18 Jul 2014 07:00:00 GMT

AbbVie and Shire seal $55B, tax-slashing deal USA Today

Shire Acquires Meritage Pharma - Technology Networks

Thu, 26 Feb 2015 08:00:00 GMT

Shire Acquires Meritage Pharma Technology Networks

Takeda's Long Battle for $62 Billion Shire Deal Gets Victory - Bloomberg.com

Wed, 05 Dec 2018 08:00:00 GMT

Takeda's Long Battle for $62 Billion Shire Deal Gets Victory Bloomberg.com

Shire gets $1.64B breakup fee from AbbVie - CBS News

Mon, 20 Oct 2014 07:00:00 GMT

Shire gets $1.64B breakup fee from AbbVie CBS News

Iconic Genzyme building faces uncertain future after Shire-Takeda deal - The Business Journals

Fri, 11 May 2018 07:00:00 GMT

Iconic Genzyme building faces uncertain future after Shire-Takeda deal The Business Journals

Takeda-Shire deal: the strategy behind Japan’s largest foreign acquisition - Pharmaceutical Technology

Mon, 02 Sep 2019 07:00:00 GMT

Takeda-Shire deal: the strategy behind Japan’s largest foreign acquisition Pharmaceutical Technology

Shire to Supply Sandoz with Authorized Adderall Generic - drugdiscoverytrends.com

Mon, 02 Dec 2013 08:00:00 GMT

Shire to Supply Sandoz with Authorized Adderall Generic drugdiscoverytrends.com

Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules as Adjunct - Fierce Biotech

Fri, 29 Oct 2010 07:00:00 GMT

Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules as Adjunct Fierce Biotech

AbbVie-Shire deal could be biggest casualty of tax-inversion crackdown - Crain's Chicago Business

Wed, 15 Oct 2014 07:00:00 GMT

AbbVie-Shire deal could be biggest casualty of tax-inversion crackdown Crain's Chicago Business

Shire applies for European approval of potential blockbuster eye drop - The Business Journals

Tue, 15 Aug 2017 07:00:00 GMT

Shire applies for European approval of potential blockbuster eye drop The Business Journals

Takeda reaches $42M settlement over ADHD drug marketing - Class Action Lawsuits

Tue, 15 Aug 2023 07:00:00 GMT

Takeda reaches $42M settlement over ADHD drug marketing Class Action Lawsuits

Jeff Poulton Appointed Shire Chief Financial Officer and Joins Board of Directors - PharmaLive

Thu, 30 Apr 2015 07:00:00 GMT

Jeff Poulton Appointed Shire Chief Financial Officer and Joins Board of Directors PharmaLive

AbbVie withdraws bid for Shire after US gets tough on tax - The Guardian

Thu, 16 Oct 2014 07:00:00 GMT

AbbVie withdraws bid for Shire after US gets tough on tax The Guardian

Shire chairman took home £8.5m - The Guardian

Thu, 22 Mar 2012 07:00:00 GMT

Shire chairman took home £8.5m The Guardian

After $62 Billion Shire Win, Takeda CEO Faces More Headaches - Bloomberg.com

Tue, 08 May 2018 07:00:00 GMT

After $62 Billion Shire Win, Takeda CEO Faces More Headaches Bloomberg.com

Shire says deal for Baxalta still on - Chicago Sun-Times

Wed, 06 Apr 2016 07:00:00 GMT

Shire says deal for Baxalta still on Chicago Sun-Times

End of the road for inversions? Abbvie drops $55 billion Shire bid - Fortune

Thu, 16 Oct 2014 07:00:00 GMT

End of the road for inversions? Abbvie drops $55 billion Shire bid Fortune

Shire backs out of deal to lease iconic Genzyme building in Cambridge - The Business Journals

Tue, 11 Sep 2018 07:00:00 GMT

Shire backs out of deal to lease iconic Genzyme building in Cambridge The Business Journals

Shire to Buy Out Partner - Inquirer.com

Wed, 21 Feb 2007 08:00:00 GMT

Shire to Buy Out Partner Inquirer.com

Big Pharma, Big Biotech: Inside Shire's ferocious recent growth in Lexington, Massachusetts - The Business Journals

Thu, 22 Sep 2016 07:00:00 GMT

Big Pharma, Big Biotech: Inside Shire's ferocious recent growth in Lexington, Massachusetts The Business Journals

Shire Shareholders Rebel Over CEO Pay - WSJ

Thu, 28 Apr 2016 07:00:00 GMT

Shire Shareholders Rebel Over CEO Pay WSJ

Shire signs Seles to raise awareness of binge eating disorder - The Boston Globe

Tue, 03 Feb 2015 08:00:00 GMT

Shire signs Seles to raise awareness of binge eating disorder The Boston Globe

Ulcerative colitis remission rates from long-term safety study of LIALDA presented at DDW - EurekAlert!

Tue, 22 May 2007 07:00:00 GMT

Ulcerative colitis remission rates from long-term safety study of LIALDA presented at DDW EurekAlert!

Shire acquires ViroPharma for $4.2bn - Financier Worldwide

Thu, 24 Apr 2014 09:00:11 GMT

Shire acquires ViroPharma for $4.2bn Financier Worldwide

Shire to lease Genzyme building as part of Kendall Square expansion - The Boston Globe

Tue, 22 Nov 2016 08:00:00 GMT

Shire to lease Genzyme building as part of Kendall Square expansion The Boston Globe

Shire on track for $20b in sales by 2020 - The Boston Globe

Tue, 02 Aug 2016 07:00:00 GMT

Shire on track for $20b in sales by 2020 The Boston Globe

Takeda Pharmaceutical, Shire get shareholders’ nod for $62-billion deal - AlphaStreet

Wed, 05 Dec 2018 08:00:00 GMT

Takeda Pharmaceutical, Shire get shareholders’ nod for $62-billion deal AlphaStreet

Dyax Corp. (DYAX), Shire PLC (ADR) (SHPG): An Interesting Bio Play in the Blood Disorder Niche - Insider Monkey

Tue, 02 Jul 2013 07:00:00 GMT

Dyax Corp. (DYAX), Shire PLC (ADR) (SHPG): An Interesting Bio Play in the Blood Disorder Niche Insider Monkey